agilon health, inc. Files 8-K with Material Agreement

TL;DR

agilon health, inc. signed a material definitive agreement, filed 8-K on Dec 4, 2024.

AI Summary

On December 4, 2024, agilon health, inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Westerville, OH.

Why It Matters

This 8-K filing indicates a significant new agreement for agilon health, inc., which could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.

Key Players & Entities

• agilon health, inc. (company) — Registrant
• December 4, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• Westerville, OH (location) — Address of Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common stock, par value $0.01 per share AGL The New York Stock Exchan

Filing Documents

• agl-20241204.htm (8-K) — 31KB
• ex-101indemnificationagree.htm (EX-10.1) — 101KB
• ex-102indemnificationagree.htm (EX-10.2) — 101KB
• 0001628280-24-050056.txt ( ) — 437KB
• agl-20241204.xsd (EX-101.SCH) — 2KB
• agl-20241204_def.xml (EX-101.DEF) — 15KB
• agl-20241204_lab.xml (EX-101.LAB) — 27KB
• agl-20241204_pre.xml (EX-101.PRE) — 16KB
• agl-20241204_htm.xml (XML) — 4KB

01 Entry Into a Material Definitive Agreement

Item 1.01 Entry Into a Material Definitive Agreement. On December 4, 2024, agilon health, inc. (the "Company") began entering into new forms of indemnification agreements with the Company's directors, executive officers, and certain other officers (each, an "Indemnitee"). The indemnification agreements provide, among other things, that, subject to certain exclusions, the Company will indemnify an Indemnitee to the fullest extent permitted by applicable law and the Company's Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws against all expenses actually and reasonably incurred and advance expenses on behalf of Indemnitee. Additionally, the new forms clarify the scope of the Company's indemnification obligations and an Indemnitee's rights. The indemnification agreements also establish various related procedures, processes and requirements. Each new indemnification agreement with a current director or officer will replace and supersede any prior indemnification agreement between the Company and such director or officer, if such director or officer was a party to a prior indemnification agreement. The foregoing summary description of the indemnification agreements is not intended to be complete and is qualified in its entirety by the complete text of the form indemnification agreements filed as Exhibit 10.1 and Exhibit 10.2 to this Form 8-K and incorporated herein by reference.

01 Other Events

Item 8.01 Other Events. On December 5, 2024, the Company changed its principal executive offices from 6210 E. Highway 290, Austin, TX 78723 to 440 Polaris Parkway, Suite 550, Westerville, OH 43082. The Company's telephone number remains the same: (562) 256-3800.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Form of Indemnification Agreement — Directors 10.2 Form of Indemnification Agreement — Officers 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. agilon health, inc. Date: December 5, 2024 By: /s/ JEFFREY SCHWANEKE Jeffrey Schwanke Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR